Literature DB >> 29043882

Ovarian volume and PCOS: a controversial issue.

Pierluigi Giampaolino1, Luigi Della Corte2, Nicoletta De Rosa2, Antonio Mercorio2, Dario Bruzzese1, Giuseppe Bifulco2.   

Abstract

Polycystic ovarian syndrome (PCOS) is a common endocrinopathy. The Rotterdam criteria indicate four distinct phenotypes. In phenotypes with the typical ovarian morphology (ovarian volume ≥10 ml) the sensibility to clomiphene citrate (CC) ovulation therapy was demonstrated inversely proportional to the ovarian volume. In this retrospective study we evaluated the influence of ovarian volume on the success rate of CC ovulation induction in women with anovulatory phenotype 2 characterized only by the presence of hyperandrogenism and anovulation (ANOV + HA). Statistical analysis was conducted by stratifying patients both on the basis of CC dose (Group 1: n = 37, 50 mg; Group 2: n = 9, 100 mg; and Group 3: n = 12, 150 mg) and on the basis of response to therapy. Eighty women were evaluated but overall only 58 women (72.5%) reached ovulation. In the phenotype studied, we didn't find any correlations between ovarian volume and the chance of ovulation with the gradient increase in CC; furthermore, ovarian volume was comparable in CC responders and non-responders. Our study has shown that in the phenotype 2 examined, ovarian volume did not have any predictive value of the dosage required to induce ovulation. The significance of this result is discussed.

Entities:  

Keywords:  PCOS; clomiphene citrate; ovarian volume; ovulation induction; phenotype 2

Mesh:

Substances:

Year:  2017        PMID: 29043882     DOI: 10.1080/09513590.2017.1391205

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

1.  Association of Polycystic Ovary Syndrome Phenotypes With Adverse Pregnancy Outcomes After In-Vitro Fertilization/Intracytoplasmic Sperm Injection.

Authors:  Qiumin Wang; Honghong Wang; Ping Li; Xiufang Li; Ze Wang; Lei Yan; Yuhua Shi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

Review 2.  Microbiome and PCOS: State-of-Art and Future Aspects.

Authors:  Pierluigi Giampaolino; Virginia Foreste; Claudia Di Filippo; Alessandra Gallo; Antonio Mercorio; Paolo Serafino; Francesco Paolo Improda; Paolo Verrazzo; Giuseppe Zara; Cira Buonfantino; Maria Borgo; Gaetano Riemma; Chiara De Angelis; Brunella Zizolfi; Giuseppe Bifulco; Luigi Della Corte
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

3.  The interplay between PCOS pathology and diet on gut microbiota in a mouse model.

Authors:  Valentina Rodriguez Paris; Xin Yi Denise Wong; Samantha M Solon-Biet; Melissa C Edwards; Ali Aflatounian; Robert B Gilchrist; Stephen J Simpson; David J Handelsman; Nadeem O Kaakoush; Kirsty A Walters
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 4.  Ovarian Drilling: Back to the Future.

Authors:  Antonio Mercorio; Luigi Della Corte; Maria Chiara De Angelis; Cira Buonfantino; Carlo Ronsini; Giuseppe Bifulco; Pierluigi Giampaolino
Journal:  Medicina (Kaunas)       Date:  2022-07-27       Impact factor: 2.948

5.  Body Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome.

Authors:  Anna Bizoń; Sylwia Płaczkowska; Justyna Niepsuj; Marta Czwojdzińska; Marcin Leśniewski; Artur Nowak; Dagmara Pluta; Paweł Madej; Agnieszka Piwowar; Grzegorz Franik
Journal:  Nutrients       Date:  2021-11-24       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.